{
    "2019-01-20": [
        [
            {
                "time": "2023-10-05",
                "original_text": "Would Pfizer Shareholders Win With an Acquisition of Amarin?",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "shareholders",
                        "acquisition",
                        "Amarin"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Which Big Pharma Stocks Lose Most in a War on Drug Price Hikes?",
                "features": {
                    "keywords": [
                        "Big Pharma",
                        "stocks",
                        "lose",
                        "drug price hikes"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}